944 Results of the first randomized controlled trial comparing intravesical radiofrequency induced chemohyperthermia with mitomycin-C versus BCG for adjuvant treatment of patients with intermediate- and high-risk non-muscle invasive bladder cancer

2015 ◽  
Vol 14 (2) ◽  
pp. e944-e944a ◽  
Author(s):  
T.J.H. Arends ◽  
O. Nativ ◽  
M. Maffezzini ◽  
O. De Cobelli ◽  
A.G. Van Der Heijden ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Controlled Trial ◽  
High Risk ◽  
Mitomycin C ◽  
Adjuvant Treatment ◽  
Controlled Trial ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Randomized Controlled ◽  
Muscle Invasive

HIVEC HR: Chemohyperthermia with mitomycin C vs BCG for high-risk non-muscle invasive bladder cancer. Preliminary results from a randomized controlled trial

2019 ◽  
Vol 18 (1) ◽  
pp. e768-e770 ◽  
Author(s):  
D.A. González Padilla ◽  
A. González Díaz ◽  
N. Miranda-Utrera ◽  
F. De La Rosa Kehrmann ◽  
F. Villacampa-Aubá ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Controlled Trial ◽  
High Risk ◽  
Mitomycin C ◽  
Controlled Trial ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Preliminary Results ◽  
Randomized Controlled ◽  
Muscle Invasive
Sign in / Sign up

Export Citation Format

Share Document